NCT01618448View on ClinicalTrials.gov

Efficacy and Safety of Tolvaptan in the Treatment of Cardiac-Induced Edema in Patients With Heart Failure

PHASE3CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

December 31, 2014

Conditions
Cardiac-induced Edema
Interventions
DRUG

Tolvaptan

Tolvaptan 15mg once daily

DRUG

Placebo

Placebo

Trial Locations (1)

Unknown

National Taiwan University Hospita, Taipei

All Listed Sponsors
lead

Taiwan Otsuka Pharm. Co., Ltd

INDUSTRY

NCT01618448 - Efficacy and Safety of Tolvaptan in the Treatment of Cardiac-Induced Edema in Patients With Heart Failure | Biotech Hunter | Biotech Hunter